abstract |
This disclosure is directed to tetrahydro-1H-pyrido [3,4-b] indole compounds or pharmaceutically acceptable salts for the adjustment of disorders mediated by estrogen, or other disorders as more fully described herein, Carbohydrates, prodrugs, stereoisomers, tautomers, rotamers, N-oxides and / or substituted derivatives, or, optionally, pharmaceutical compositions. |